BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4049789)

  • 1. [Mechanism of enzymatic imprinting induced in rats by an early postnatal administration of galactose].
    Salganik RI; Solov'eva NA; Knorre VL; Tomsons VP; Iurkina EA
    Vopr Med Khim; 1985; 31(4):65-70. PubMed ID: 4049789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of neonatal induction of enzymes for the correction of experimental hereditary enzymopathies].
    Salganik RI; Solov'eva NA; Manankova NM; Tomsons VP
    Vopr Med Khim; 1982; 28(3):8-15. PubMed ID: 6179300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correction of the symptoms of hereditary galactosemia in W/SSM strain rats by enzymatic imprinting].
    Salganik RI; Solov'eva NA; Kandaurov VV
    Genetika; 1982 Mar; 18(3):428-33. PubMed ID: 7200439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enzymatic "imprinting" as a result of exposure to genetic enzyme inducers soon after the birth of animals].
    Salganik RI; Griaznova IM; Markel' AL; Manankova NM; Solov'eva NA
    Dokl Akad Nauk SSSR; 1979; 245(2):473-6. PubMed ID: 35317
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hereditary galactosemia in rats: biochemical mechanisms of the disease].
    Solov'eva NA; Kandaurov VA; Zaĭdman AM; Salganik RI
    Vopr Med Khim; 1982; 28(3):15-21. PubMed ID: 6213094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stimulation of DNA synthesis and mitoses in the rat liver in experimental galactosemia caused by the prolonged administration of galactose].
    Kostyrev OA; Solov'eva NA
    Tsitologiia; 1975 Sep; 17(9):1042-6. PubMed ID: 1166519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of a rat subline with symptoms of hereditary galactosemia and study of its biochemical characteristics].
    Solov'eva NA; Morozkova TS; Salganik RI
    Genetika; 1975; 11(5):63-71. PubMed ID: 1240812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; galactosemia and galactose-1-phosphate uridyltransferase deficiency].
    Bosch AM; Waterham HR; Bakker HD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):80-1. PubMed ID: 14753129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of rat tissue galactose-1-phosphate uridyltransferase by uridine and uridine triphosphate.
    Rogers S; Segal S
    Pediatr Res; 1991 Sep; 30(3):222-6. PubMed ID: 1945559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical mechanisms of the development of hereditary galactosemia in W/SSM strain rats].
    Solov'eva NA; Salganik RI
    Genetika; 1982 Mar; 18(3):420-7. PubMed ID: 7200438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactosemia caused by a point mutation that activates cryptic donor splice site in the galactose-1-phosphate uridyltransferase gene.
    Wadelius C; Lagerkvist A; Molin AK; Larsson A; von Döbeln U; Pettersson U
    Genomics; 1993 Aug; 17(2):525-6. PubMed ID: 8406510
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathological findings in galactosemia caused by a galactose-1-phosphaturidyltransferase defect (author's transl)].
    Gathmann HA
    Klin Padiatr; 1977 Mar; 189(2):177-84. PubMed ID: 558474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UDP-galactose pyrophosphorylase in mice with galactose-1-phosphate uridyltransferase deficiency.
    Leslie N; Yager C; Reynolds R; Segal S
    Mol Genet Metab; 2005 May; 85(1):21-7. PubMed ID: 15862277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways of galactose metabolism by galactosemics: evidence for galactose conversion to hepatic UDPglucose.
    Segal S; Wehrli S; Yager C; Reynolds R
    Mol Genet Metab; 2006 Feb; 87(2):92-101. PubMed ID: 16260165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the RNA-dependent DNA-polymerase activity of retrovirus-like particles in the rat liver during postnatal ontogeny].
    Pyrinova GB; Korokhov NP; Kiseleva EV; Tomsons VP; Khristoliubova NB
    Ontogenez; 1984; 15(6):637-43. PubMed ID: 6084211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for alternate galactose oxidation in a patient with deletion of the galactose-1-phosphate uridyltransferase gene.
    Berry GT; Leslie N; Reynolds R; Yager CT; Segal S
    Mol Genet Metab; 2001 Apr; 72(4):316-21. PubMed ID: 11286505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duarte allele impairs biostability of galactose-1-phosphate uridyltransferase in human lymphoblasts.
    Lai K; Langley SD; Dembure PP; Hjelm LN; Elsas LJ
    Hum Mutat; 1998; 11(1):28-38. PubMed ID: 9450900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stable changes in the nuclear matrix activity and DNA structure of the liver in rats due to neonatal induction of gene expression].
    Salganik RI; Knorre VL; Drevich VF; Morozova OV; Zaĭchikov EF
    Dokl Akad Nauk SSSR; 1985; 281(5):1237-41. PubMed ID: 2408837
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic fate of administered [13C]galactose in tissues of galactose-1-phosphate uridyl transferase deficient mice determined by nuclear magnetic resonance.
    Wehrli S; Reynolds R; Segal S
    Mol Genet Metab; 2007 Jan; 90(1):42-8. PubMed ID: 16935536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of the human galactose-1-phosphate uridyltransferase promoter in Duarte and LA variant galactosemia.
    Elsas LJ; Lai K; Saunders CJ; Langley SD
    Mol Genet Metab; 2001 Apr; 72(4):297-305. PubMed ID: 11286503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.